Doptelet (Avatrombopag Maleate)
Doptelet (Avatrombopag Maleate)
Doptelet (avatrombopag) is an oral thrombopoietin receptor agonist used to treat low platelet counts (thrombocytopenia) in adults with chronic liver disease scheduled for a medical procedure, or in patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to previous treatments. It works by stimulating platelet production in the bone marrow.
Delivery
5-7 day
In Stock
Yes
Guaranteed
Source Canadian/UK PharmaciesDoptelet (generic name: avatrombopag) is a prescription medicine that stimulates platelet production by activating the thrombopoietin (TPO) receptor. It is indicated for:
-
Treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
-
Treatment of chronic immune thrombocytopenia (ITP) in adults who have not adequately responded to previous treatments such as corticosteroids, immunoglobulins, or splenectomy.
Unlike some other TPO receptor agonists, Doptelet is taken orally with food and does not require dietary restrictions related to polyvalent cations. By increasing platelet counts, it helps reduce the risk of bleeding and the need for platelet transfusions.